Tumor-targeting properties of 90Y- and 177Lu-labeled α-melanocyte stimulating hormone peptide analogues in a murine melanoma model

High tumor-targeting properties of 90Y-DOTA-Re(Arg11)CCMSH and 177Lu-DOTA-Re(Arg11)CCMSH highlighted their potential as radiopharmaceuticals for targeted radionuclide therapy of melanoma in further investigations.